Radboudumc
Nijmegen, Netherlands
NCT Number: NCT05478122
Rationale:
Effective and fast topical anaesthesia of the upper airway is of paramount importance in awake (conscious) videolaryngoscopy of the airway in order to avoid patient discomfort. Different methods of anesthetizing the airway have been described. Conventional topical airway anaesthesia is not always effective due to non-optimal flow patterns and generation of ineffective local anaesthetic aerosols. Other methods of anaesthetizing the airway are more invasive. In order to optimize topical anaesthesia of the airway a soft mist spray device (Trachospray) for topical anaesthesia of the airway has been developed, in which optimal airflow patterns are obtained and local anaesthetic aerosols are generated which will reach the target zone for anesthetizing the airway.
Objective: In this study, the Trachospray will be used for awake videolaryngoscopy, to evaluate its use, effectiveness and comfort level for patients and anaesthesiologist.
Study design: Interventional study.
Study population: 20 healthy human volunteers, ASA 1, 18-60 years old.
Intervention: Subjects will be asked to inhale 4 ml lidocaine 4% via the Trachospray device
Main study parameters/endpoints:
Anaesthesia of the airway as evaluated with successful awake videolaryngoscopy with minimal discomfort for the subject.
Nature and extent of the burden and risks associated with participation:
Risk management on the Trachospray device shows that all user risks are mitigated and no residual risks remain for the use of the device. Testing of the device and the application of the device in daily practice has no additional risks than the present technique of performing anaesthesia of the airways.There may be some discomfort during the procedure, mainly airway irritation which may cause coughing or gag reflex.
Looking for future studies?
Notify Me18 year–60 year
All sexes
Interventional
Not applicable
Nijmegen, Netherlands
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Subjects will be asked to inhale 4 ml lidocaine 4% via the Trachospray device
Time frame: 3 months
Discomfort and level of anesthesia will be measured with a numerical rating scale (NRS). 60 / 5.000 Vertaalresultaten So the result will be displayed in whole numbers.
Radboud University Medical Center
Other
Acronym: CT2Trachospray
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06245668
Airway, Anesthesia
Samsun, Turkey (Türkiye)
View Trial DetailsNCT06174896
Airway, Anesthesia
Samsun, Turkey (Türkiye)
View Trial DetailsNCT06356298
Adenotonsillectomy, Airway
Wuhan, Hubei, China
View Trial DetailsNCT04533334
Airway, Bronchus
Istanbul, Turkey (Türkiye)
View Trial Details